TARO - Taro Pharmaceutical Industries Ltd.
| Previous Close | 100.73 |
| Open | 101.02 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 100.62 - 101.78 |
| 52 Week Range | 93.01 - 128.46 |
| Volume | 24,696 |
| Avg. Volume | 90,242 |
| Market Cap | 4.055B |
| Beta | 0.40 |
| PE Ratio (TTM) | 19.64 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Markit•16 days agoSee what the IHS Markit Score report has to say about Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd NYSE:TARO
- Simply Wall St.•18 days ago
At $97.85, Is Taro Pharmaceutical Industries Ltd (NYSE:TARO) A Buy?
Taro Pharmaceutical Industries Ltd (NYSE:TARO), a pharmaceuticals company based in Israel, received a lot of attention from a substantial price movement on the NYSE in the over the last fewRead More...
- Simply Wall St.•last month
Should You Be Tempted To Buy Taro Pharmaceutical Industries Ltd (NYSE:TARO) Because Of Its PE Ratio?
Taro Pharmaceutical Industries Ltd (NYSE:TARO) is trading with a trailing P/E of 19.4x, which is lower than the industry average of 22x. While TARO might seem like an attractive stockRead More...
Markit•last monthSee what the IHS Markit Score report has to say about Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd NYSE:TARO
- Simply Wall St.•2 months ago
Where Taro Pharmaceutical Industries Ltd (NYSE:TARO) Stands In Terms Of Earnings Growth Against Its Industry
Increase in profitability and industry-beating performance can be essential considerations in a stock for some investors. In this article, I will take a look at Taro Pharmaceutical Industries Ltd’s (NYSE:TARO)Read More...
Markit•2 months agoSee what the IHS Markit Score report has to say about Taro Pharmaceutical Industries Ltd.
Short interest is low for TARO with fewer than 5% of shares on loan. The net inflows of $2.08 billion over the last one-month into ETFs that hold TARO are among the lowest of the last year and appear to be slowing.
Markit•2 months agoSee what the IHS Markit Score report has to say about Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd NYSE:TARO
- Associated Press•2 months ago
Taro posts 3Q profit
The Haifa Bay, Israel-based company said it had profit of 45 cents per share. Earnings, adjusted for pretax expenses and to account for discontinued operations, came to $1.37 per share. The drug maker ...
- Simply Wall St.•4 months ago
Is It Too Late To Buy Taro Pharmaceutical Industries Ltd (NYSE:TARO)?
Taro Pharmaceutical Industries Ltd (NYSE:TARO), a pharmaceuticals company based in Israel, received a lot of attention from a substantial price movement on the NYSE in the over the last fewRead More...
- Simply Wall St.•4 months ago
How Taro Pharmaceutical Industries Ltd (NYSE:TARO) Delivered A Better ROE Than Its Industry
Taro Pharmaceutical Industries Ltd (NYSE:TARO) outperformed the Pharmaceuticals industry on the basis of its ROE – producing a higher 16.01% relative to the peer average of 11.92% over the pastRead More...
Markit•4 months agoSee what the IHS Markit Score report has to say about Taro Pharmaceutical Industries Ltd.
Short interest is low for TARO with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.
- Capital Cube•5 months ago
ETFs with exposure to Taro Pharmaceutical Industries Ltd. : December 1, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Taro Pharmaceutical Industries Ltd. Here are 5 ETFs with the largest exposure to TARO-US. Comparing the performance and risk of Taro Pharmaceutical Industries Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)
GuruFocus.com•5 months agoCharles Brandes Picks Up 5 Stocks in 3rd Quarter
Guru invests in advertising, auto parts, pharmaceutical and communication equipment companies
- Capital Cube•5 months ago
Taro Pharmaceutical Industries Ltd. breached its 50 day moving average in a Bearish Manner : TARO-US : November 23, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Taro Pharmaceutical Industries Ltd.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)
- Thomson Reuters StreetEvents•5 months ago
Edited Transcript of TARO earnings conference call or presentation 8-Nov-17 1:00pm GMT
Q2 2018 Taro Pharmaceutical Industries Ltd Earnings Call
- Capital Cube•5 months ago
ETFs with exposure to Taro Pharmaceutical Industries Ltd. : November 16, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Taro Pharmaceutical Industries Ltd. Here are 5 ETFs with the largest exposure to TARO-US. Comparing the performance and risk of Taro Pharmaceutical Industries Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)
Markit•5 months agoSee what the IHS Markit Score report has to say about Taro Pharmaceutical Industries Ltd.
Short interest is low for TARO with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. The net inflows of $1.59 billion over the last one-month into ETFs that hold TARO are among the lowest of the last year and appear to be slowing.
- Investor's Business Daily•5 months ago
Taro Pharmaceutical Industries Earns RS Rating Upgrade
Taro Pharmaceutical Industries shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
- Associated Press•5 months ago
Taro posts 2Q profit
The Haifa Bay, Israel-based company said it had profit of $1.30 per share. The drug maker posted revenue of $169.9 million in the period. Taro shares have climbed almost 5 percent since the beginning of ...
Markit•5 months agoSee what the IHS Markit Score report has to say about Taro Pharmaceutical Industries Ltd.
Short interest is low for TARO with fewer than 5% of shares on loan. The net inflows of $1.71 billion over the last one-month into ETFs that hold TARO are among the lowest of the last year and appear to be slowing.
- Capital Cube•6 months ago
Taro Pharmaceutical Industries Ltd. breached its 50 day moving average in a Bearish Manner : TARO-US : October 19, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Taro Pharmaceutical Industries Ltd.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)
